CoChat

Telecare Provides Comparable Efficacy to Conventional Self-Monitored Blood Glucose in Patients with Type 2 Diabetes Titrating One Injection of Insulin Glulisine—the ELEONOR Study

Open access
Prato, Stefano Del, Nicolucci, Antonio, Lovagnini-Scher, Augusto C., Turco, Salvatore, Leotta, Sergio, Vespasiani, Giacomo · 2012 · Diabetes Technology & Therapeutics
Cited by 54

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

BACKGROUND: We compared telecare and conventional self-monitored blood glucose (SMBG) programs for titrating the addition of one bolus injection of insulin glulisine in patients with type 2 diabetes uncontrolled on oral hypoglycemic agents for ≥3 months who were first titrated with basal insulin glargine. METHODS: This randomized, multicenter, parallel-group study included 241 patients (mean screening glycosylated hemoglobin [HbA(1c)], 8.8% [73 mmol/mol]). In the run-in phase, any antidiabetes medication, except for metformin, was discontinued. Metformin was then up-titrated to 2 g/day (1 g twice daily) until study completion. Following run-in, all patients started glargine for 8-16 weeks, targeting fasting plasma glucose (FPG) ≤5.6 mmol/L using conventional SMBG. Patients with FPG ≤7 mmol/L added a glulisine dose at the meal with the highest postprandial plasma glucose excursion, titrated to target 2-h postprandial plasma glucose level <7.8 mmol/L using telecare or SMBG for 24 weeks. Patients with FPG >7 mmol/L at week 16 were withdrawn from the study. RESULTS: After glargine titration, 224 patients achieved FPG ≤7 mmol/L, without any difference between telecare and SBMG groups (mean±SD, 6.2±0.8 vs. 6.0±0. 9 mmol/L, respectively). HbA(1c) levels were lower following titration and were similar for telecare and SMBG (7.9±0.9% vs. 7.8±0.9% [63 vs. 62 mmol/mol], respectively). Adding glulisine further reduced HbA(1c) in both groups (-0.7% vs. -0.7%); 45.2% and 54.8% (P=0.14), respectively, of patients achieved HbA(1c) ≤7.0% (≤53 mmol/mol). Weight change and hypoglycemia were similar between groups. CONCLUSIONS: Patients adding one dose of glulisine at the meal with the highest postprandial plasma glucose excursion to titrated basal glargine achieved comparable improvements in glycemic control irrespective of traditional or telecare blood glucose monitoring.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/dia.2011.0163

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 15

  1. 10.1016/S0169-2607(02)00037-8 · DOI
  2. 10.1016/S0169-2607(02)00039-1 · DOI · Paper page
  3. 10.1111/j.1463-1326.2008.00980.x · DOI · Paper page
  4. 10.1111/j.1463-1326.2008.00967.x · DOI
  5. 10.1111/j.1463-1326.2008.00846.x · DOI · Paper page
  6. 10.1002/dmrr.733 · DOI
  7. 10.1111/j.1463-1326.2011.01459.x · DOI · Paper page
  8. 10.1089/dia.2008.0114 · DOI · Paper page
  9. 10.2337/diacare.26.11.3080 · DOI
  10. 10.2337/dc11-0900 · DOI
  11. 10.2337/dc07-2137 · DOI · Paper page
  12. 10.1016/j.diabres.2004.03.003 · DOI · Paper page
  13. 10.1016/j.clinthera.2008.11.001 · DOI · Paper page
  14. 10.1002/dmrr.989 · DOI
  15. 10.2147/VHRM.S10952 · DOI · Paper page

Cited by

Metadata

Authors
Prato, S. D., Nicolucci, A., Lovagnini-Scher, A. C., Turco, S., Leotta, S., & Vespasiani, G.
Venue
Diabetes Technology & Therapeutics
Published
2012-02
Volume
14
Issue
2
Pages
175-182
ISSN
  • 1520-9156 (ISSN-L)
  • 1557-8593
OpenAlex
W1982616521
Cited by
54
References
7
FWCI
4.94
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.